{
  "id": 3544,
  "text": "Eur J Surg Oncol 38, 948- 954 (2012).1523.Yoo, H.J., et al.Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.J Gynecol Oncol 23, 242-250 (2012).1524.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Eur J Surg Oncol 38, 948- 954 (2012).1523.Yoo, H.J., et al.Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.J Gynecol Oncol 23, 242-250 (2012).1524.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在治疗复发性宫颈癌时，盆腔清除术（Pelvic Exenteration）是一种针对局部晚期或复发性宫颈癌患者的重要治疗手段。根据相关研究，长期效果主要取决于患者的肿瘤分期、复发部位、手术范围、以及是否伴随远处转移。\n\n盆腔清除术的长期生存率在可接受的患者中可以达到40%-50%，尤其是当复发局限于盆腔且没有远处转移时，预后相对较好。然而，该手术的术后并发症发生率较高（如术后感染、伤口愈合问题、泌尿系统并发症），因此患者的术前评估和术后管理至关重要。\n\n此外，研究也表明，术前综合评估包括影像学检查（如MRI、PET-CT）以及系统性排查远端转移，可有效帮助筛选适合接受手术的患者，最大限度提高生存率并减少术后不良反应。",
  "query": "这段内容确实与宫颈癌复发相关，不属于要求跳过的范围。\n\n**Question: 在治疗复发性宫颈癌时，如何评价盆腔清除术的长期效果？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这段内容确实与宫颈癌复发相关，不属于要求跳过的范围。\n\n**Question: 在治疗复发性宫颈癌时，如何评价盆腔清除术的长期效果？**\n\n<reference text>: Eur J Surg Oncol 38, 948- 954 (2012).1523.Yoo, H.J., et al.Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.J Gynecol Oncol 23, 242-250 (2012).1524.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在治疗复发性宫颈癌时，盆腔清除术（Pelvic Exenteration）是一种针对局部晚期或复发性宫颈癌患者的重要治疗手段。根据相关研究，长期效果主要取决于患者的肿瘤分期、复发部位、手术范围、以及是否伴随远处转移。\n\n盆腔清除术的长期生存率在可接受的患者中可以达到40%-50%，尤其是当复发局限于盆腔且没有远处转移时，预后相对较好。然而，该手术的术后并发症发生率较高（如术后感染、伤口愈合问题、泌尿系统并发症），因此患者的术前评估和术后管理至关重要。\n\n此外，研究也表明，术前综合评估包括影像学检查（如MRI、PET-CT）以及系统性排查远端转移，可有效帮助筛选适合接受手术的患者，最大限度提高生存率并减少术后不良反应。"
}